Skip to content
Sign In Subscribe
WSJ — Business — Infection Risk — Drugs — Recalls — FDA

Eye Drops Recalled by Two Companies Over Safety Concerns

Two companies have recalled eye drops due to safety risks that could cause infections and other problems. The recalled drops were distributed in the U.S. from April 2022 to Feb. 2023.

1 min read
  • Two companies have recalled eye drops over safety risks that could cause infections and other problems.
  • Apotex Corp. recalled its Brimonidine Tartrate Ophthalmic Solution due to cracks that developed in some bottle caps.
  • Pharmedica recalled Purely Soothing 15% MSM Drops due to contamination.
Eye Drops Recalled by Two Companies Over Safety Concerns
Health officials last month warned consumers over infection risk from another eye-drop brand
WSJTalal Ansari

More in Business

More from WSJ

Latest